OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Angie Drakulich was editorial director of BioPharm International.
FDA talks about the changing scope of regulatory science.
Our editorial advisory board members provide their perspective on what's ahead in the biopharmaceutical industry.
A recent ISPE guidance provides a baseline for the design of quality laboratory facilities.
Keeping tabs on crucial medicines should be part of consumers' and manufacturers' emergency-preparedness plans.